As food stays in your system longer, you feel fuller for longer and eat less
Our team ensures that all aspects of your health are considered before starting treatment, including screening for any contraindications, such as thyroid conditions or a history of pancreatitis
Regular follow-ups with healthcare providers can help ensure that the treatment remains effective and safe, allowing for any necessary adjustments to be made based on the patient's response
A phase 3 trial of hydralazine (NCT04842552) was started in August 2021 and is anticipated to be completed in December 2023
This genetic insight helps your provider select your ideal starting dose and escalation timeline, personalizing your therapy from day one
Dinner choices also matter, with GLP-1 dinner ideas emphasizing balanced macronutrients that support overnight metabolic function